Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Explore the best cash back rewards credit cards and optimize your spending to get rewarded effectively. Discover your top picks today!
23,783 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Airbnb’s latest quarterly results reinforce that airbnb’s billion growth story is far from peaking, underscored by ro...
Imagine a space tech powerhouse going public and shaping Wall Street expectations. This article lays out three plausi...
Joby Aviation is set to report Q4 2025 results after the market close tonight. Analysts will track revenue, cash burn...
In February, Fluor Corp. shares kept climbing as demand for infrastructure and energy projects stayed resilient. This...
G-III Apparel faces a pivotal year in 2026 as licensing momentum and margin discipline collide with shifting consumer...
Disney's stock is under renewed pressure as its core businesses face slower growth. The market is awaiting clearer pr...
High-income investors face a tax cliff with JEPI: the 8% distribution yield is largely ordinary income, trimming real...
A long-running dividend ETF marks 22 years of payments as retirees continue to seek steady income in a shifting marke...
C3.AI topped Q4 expectations and provided FY27 guidance, sending shares higher after hours as investors weigh the com...
Broadcom delivered solid quarterly results, but AI guidance disappointed some investors, sending shares lower. Analys...
A major U.S. player in rare-earth magnets has fallen from its peak as policy shifts promise supply-chain resilience. ...